Filing metadata

Accession number
0001641172-25-026025
Form type
Form 4
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Aug 29, 2025
Reporting period
Aug 21, 2025
Description
Insider transaction

Explore SEC Filings Hub